Recent Developments at DG Competition: 2017/2018
Andrea Amelio1, Thomas Buettner2, Cyril Hariton3
11Directorate-General for Competition, European Commission, MADO 18/058, 1049 Brussels, Belgium.
Summary
The European Commission
Area of Science:
- Competition Law
- Antitrust
- Merger Control
- State Aid
Background:
- The Directorate General for Competition (DG COMP) enforces EU competition law.
- Key areas include antitrust, merger control, and state aid.
- The Chief Competition Economist's team plays a vital role.
Purpose of the Study:
- To present the role of the Chief Competition Economist's team.
- To survey DG COMP achievements in 2017/2018.
- To review specific competition cases and methodologies.
Main Methods:
- Review of DG COMP activities and case law.
- Analysis of the Google Search (Shopping) case.
- Examination of price discrimination in state aid.
- Assessment of counterfactuals in merger analysis.
Main Results:
- Overview of DG COMP's 2017/2018 achievements.
- Insights into the Google Search (Shopping) decision.
- Understanding the application of price discrimination in state aid.
- Evaluation of counterfactual methodologies in merger reviews.
Conclusions:
- DG COMP actively enforces competition law across key domains.
- Specific cases highlight the complexity of antitrust and merger reviews.
- Methodological approaches, like counterfactuals, are crucial for effective enforcement.
Related Concept Videos
Competition
24.8K
When organisms require the same limited resources within an environment, they may have to compete for them. Competition is a net-negative interaction. Even if two competing individuals or populations do not interact directly, the overall fitness of both competitors is lowered as a result of not having full access to the limited resource.
24.8K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
797
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
797
Sustainable Development
15.1K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.1K
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.9K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.9K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
973
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
973
Development of the Lymphatic System
2.1K
The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.1K


